乳房再発スコア検査に関する市場調査:この分野で地域市場をリードする北米Market Study on Breast Recurrence Score Tests: North America Leading Regional Market in This Space 乳房再発スコア検査市場:レポート範囲 Persistence Market Research社の最新レポート「世界の乳房再発スコア検査市場」は、市場機会と現在の市場展望を評価し、市場に影響を与える対応セクションに関する詳細... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー乳房再発スコア検査市場:レポート範囲Persistence Market Research社の最新レポート「世界の乳房再発スコア検査市場」は、市場機会と現在の市場展望を評価し、市場に影響を与える対応セクションに関する詳細な分析と最新情報を提供しています。この調査レポートは、市場の促進要因、阻害要因、動向、機会を含む現在の市場ダイナミクスに関する詳細な洞察を提供しています。市場調査の主な目的は、2023年から2033年の予測期間中に市場がどのように推移するかについての独占情報を提示することです。 市場の成功成長のための重要な指標は、市場の前年比(YoY)成長分析、複合年間成長率(CAGR)を含むこの包括的なレポートで提示され、Persistence Market Research社の調査で網羅的に説明されています。この調査レポートは、乳房再発スコア検査製品の需要と調査期間中の定量的な発展機会を知る読者を支援することができます。 本調査は、投資家、メーカー、サービスプロバイダ、流通業者、サプライヤなどのランドスケープにおける株主にとって有益であり、乳房再発スコア検査市場で繁栄するための適切な事業戦略を策定する際に役立ちます。乳房再発スコア検査市場の株主、業界専門家、投資家、研究者、報道関係者、ビジネス愛好家は、このPersistence Market Researchの調査レポートで紹介されている洞察や情報を活用することができます。 市場統計、ならびに乳房再発スコア検査市場のビジネスシナリオに影響を与えるマクロ経済変数およびマクロ経済変数に関連する情報も、本調査に含まれています。市場の潜在的な発展に応じて、実質的な洞察もこのレポートで遭遇します。さらに、本レポートで提出されたデータにより、業界のマイナー企業や新規参入企業は、市場での牽引力を達成するために適切な企業選択を行う際に役立ちます。 主要市場セグメント Persistence Market Research社の乳房再発スコア検査市場に関する調査レポートは、製品、適応症、エンドユーザー、地域の4つの重要なセグメントに分けた情報を提供しています。本レポートは、これらのカテゴリに関連する重要な市場ダイナミクスと成長パラメータに関する包括的なデータと情報を提供します。 属性詳細 製品 検査キット 試薬・消耗品 適応症 ステージ1乳がん ステージ2乳がん エストロゲン受容体陽性がん リンパ節転移陰性がん エンドユーザー 病院 専門がんセンター 診断センター がん研究機関 地域 北米 ラテンアメリカ ヨーロッパ 南アジア 東アジア オセアニア 中東・アフリカ(MEA) レポートで回答した主な質問 今後数年間、乳房再発スコア検査製品にとって最も収益性の高い市場であり続けるのはどの地域か? トレンドの変化は市場にどのような影響を与えるか? 市場プレイヤーは先進地域の低空飛行チャンスをどのように捉えることができるか? このような状況において、利害関係者はどのような戦略で自らのポジションを確立しているのか? 投資家が市場に投資する際に注意すべき、また取り組む可能性のある阻害要因は何か? 市場に影響を与える開発動向は何か? 乳房再発スコア検査市場の企業は、先進国および新興国の成長機会をどのように利用できるか? 調査方法 Persistence Market Research社の調査レポートでは、乳房再発スコア検査市場の成長に関する広範な調査を実施し、市場の今後の成長パラメータに関する結論を得るために、独自の調査手法を活用しています。この調査手法は一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。 市場調査作成中にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは、一次資料として本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行った。 一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、乳房再発スコア検査市場の成長見通しに関するPersistence Market Research社の予測をより正確で信頼性の高いものにしています。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption Analysis 4.2. Product USPs/Features 4.3. Regulatory Landscape, By Country 4.4. Recent Product Approval/Launches 4.5. Disease Epidemiology 4.6. PESTLE Analysis 4.7. Value Chain Analysis 4.8. Unmet Needs 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure Outlook 5.1.2. Global Life Science Market Outlook 5.1.3. Global Breast Cancer Diagnostics Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising Prevalence of Breast Cancer 5.2.2. Increase in Research and Development 5.2.3. Strategic Collaborations among players 5.2.4. Cost of Product 5.2.5. Adoption Rate 5.2.6. Frequency of Product Approval 5.2.7. Government Initiative 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand Volume (Units) Analysis 2017–2022 and Forecast, 2023–2033 6.1. Historical Market Volume (Units) Analysis, 2017–2022 6.2. Current and Future Market Volume (Units) Projections, 2023–2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market – Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Global Average Pricing Analysis Benchmark 7.3. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017–2022 and Forecast, 2023–2033 8.1. Historical Market Value (US$ Mn) Analysis, 2017–2022 8.2. Current and Future Market Size (US$ Mn) Projections, 2023–2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic 9. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2017–2022 9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2023–2033 9.3.1. Test Kits 9.3.2. Reagents & Consumables 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Indication 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2017–2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023–2033 10.3.1. Stage 1 Breast Cancer 10.3.2. Stage 2 Breast Cancer 10.3.3. Estrogen-receptor Positive Cancer 10.3.4. Lymph-node Negative Cancer 10.4. Market Attractiveness Analysis By Indication 11. Global Market Analysis 2017–2022 and Forecast 2023–2033, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033 11.3.1. Hospitals 11.3.2. Specialty Cancer Centers 11.3.3. Diagnostic Centers 11.3.4. Cancer Research Institutions 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2017–2022 and Forecast 2023–2033, by Region 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2017–2022 12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Region, 2023–2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East and Africa 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2017–2022 and Forecast 2023–2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Indication 13.3.4. By End User 13.4. Market Attractiveness Analysis By Region 13.4.1. By Country 13.4.2. By Product 13.4.3. By Indication 13.4.4. By End User 13.5. Market trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country Level Analysis & Forecast 13.8.1. U.S. Market Analysis 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Product 13.8.1.2.2. By Indication 13.8.1.2.3. By End User 13.8.2. Canada Market Analysis 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Product 13.8.2.2.2. By Indication 13.8.2.2.3. By End User 14. Latin America Market Analysis 2017–2022 and Forecast 2023–2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By Indication 14.3.4. By End User 14.4. Market Attractiveness Analysis By Region 14.4.1. By Country 14.4.2. By Product 14.4.3. By Indication 14.4.4. By End User 14.5. Market trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. Brazil Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Product 14.8.1.2.2. By Indication 14.8.1.2.3. By End User 14.8.2. Mexico Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Product 14.8.2.2.2. By Indication 14.8.2.2.3. By End User 14.8.3. Argentina Market Analysis 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Product 14.8.3.2.2. By Indication 14.8.3.2.3. Type By End User 15. Europe Market Analysis 2017–2022 and Forecast 2023–2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2017–2022 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. France 15.3.1.3. Spain 15.3.1.4. Russia 15.3.1.5. Italy 15.3.1.6. BENELUX 15.3.1.7. U.K. 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By Indication 15.3.4. By End User 15.4. Market Attractiveness Analysis By Region 15.4.1. By Country 15.4.2. By Product 15.4.3. By Indication 15.4.4. By End User 15.5. Market trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. Germany Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By Indication 15.8.1.2.3. By End User 15.8.2. France Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By Indication 15.8.2.2.3. By End User 15.8.3. Spain Market Analysis 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Product 15.8.3.2.2. By Indication 15.8.3.2.3. Type By End User 15.8.4. Russia Market Analysis 15.8.4.1. Introduction 15.8.4.2. Market Analysis and Forecast by Market Taxonomy 15.8.4.2.1. By Product 15.8.4.2.2. By Indication 15.8.4.2.3. Type By End User 15.8.5. Italy Market Analysis 15.8.5.1. Introduction 15.8.5.2. Market Analysis and Forecast by Market Taxonomy 15.8.5.2.1. By Product 15.8.5.2.2. By Indication 15.8.5.2.3. By End User 15.8.6. BENELUX Market Analysis 15.8.6.1. Introduction 15.8.6.2. Market Analysis and Forecast by Market Taxonomy 15.8.6.2.1. By Product 15.8.6.2.2. By Indication 15.8.6.2.3. By End User 15.8.7. U.K. Market Analysis 15.8.7.1. Introduction 15.8.7.2. Market Analysis and Forecast by Market Taxonomy 15.8.7.2.1. By Product 15.8.7.2.2. By Indication 15.8.7.2.3. By End User 16. East Asia Market Analysis 2017–2022 and Forecast 2023–2033 16.1. Introduction / Key Findings 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Product 16.3.3. By Indication 16.3.4. By End User 16.4. Market Attractiveness Analysis By Region 16.4.1. By Country 16.4.2. By Product 16.4.3. By Indication 16.4.4. By End User 16.5. Market trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. China Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By Indication 16.8.1.2.3. By End User 16.8.2. Japan Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By Indication 16.8.2.2.3. By End User 16.8.3. South Korea Market Analysis 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By Indication 16.8.3.2.3. By End User 17. South Asia Market Analysis 2017–2022 and Forecast 2023–2033 17.1. Introduction / Key Findings 17.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2017–2022 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Indonesia 17.3.1.3. Thailand 17.3.1.4. Philippines 17.3.1.5. Malaysia 17.3.1.6. Vietnam 17.3.1.7. Rest of South Asia 17.3.2. By Product 17.3.3. By Indication 17.3.4. By End User 17.4. Market Attractiveness Analysis By Region 17.4.1. By Country 17.4.2. By Product 17.4.3. By Indication 17.4.4. By End User 17.5. Market trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. India Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Indication 17.8.1.2.3. By End User 17.8.2. Indonesia Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Indication 17.8.2.2.3. By End User 17.8.3. Thailand Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By Indication 17.8.3.2.3. By End User 17.8.4. Philippines Market Analysis 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Product 17.8.4.2.2. By Indication 17.8.4.2.3. By End User 17.8.5. Malaysia Market Analysis 17.8.5.1. Introduction 17.8.5.2. Market Analysis and Forecast by Market Taxonomy 17.8.5.2.1. By Product 17.8.5.2.2. By Indication 17.8.5.2.3. By End User 17.8.6. Vietnam Market Analysis 17.8.6.1. Introduction 17.8.6.2. Market Analysis and Forecast by Market Taxonomy 17.8.6.2.1. By Product 17.8.6.2.2. By Indication 17.8.6.2.3. By End User 18. Oceania Market Analysis 2017–2022 and Forecast 2023–2033 18.1. Introduction / Key Findings 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022 18.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Indication 18.3.4. By End User 18.4. Market Attractiveness Analysis By Region 18.4.1. By Country 18.4.2. By Product 18.4.3. By Indication 18.4.4. By End User 18.5. Market trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. Australia Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Indication 18.8.1.2.3. By End User 18.8.2. New Zealand Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Indication 18.8.2.2.3. By End User 19. Middle East and Africa Market Analysis 2017–2022 and Forecast 2023–2033 19.1. Introduction / Key Findings 19.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2017–2022 19.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. Egypt 19.3.1.4. Israel 19.3.1.5. South Africa 19.3.1.6. Northern Africa 19.3.1.7. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Indication 19.3.4. By End User 19.4. Market Attractiveness Analysis By Region 19.4.1. By Country 19.4.2. By Product 19.4.3. By Indication 19.4.4. By End User 19.5. Market trends 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country Level Analysis & Forecast 19.8.1. GCC Countries Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Indication 19.8.1.2.3. By End User 19.8.2. Türkiye Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Indication 19.8.2.2.3. By End User 19.8.3. Egypt Market Analysis 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By Indication 19.8.3.2.3. By End User 19.8.4. Israel Market Analysis 19.8.4.1. Introduction 19.8.4.2. Market Analysis and Forecast by Market Taxonomy 19.8.4.2.1. By Product 19.8.4.2.2. By Indication 19.8.4.2.3. By End User 19.8.5. South Africa Market Analysis 19.8.5.1. Introduction 19.8.5.2. Market Analysis and Forecast by Market Taxonomy 19.8.5.2.1. By Product 19.8.5.2.2. By Indication 19.8.5.2.3. By End User 19.8.6. Northern Africa Market Analysis 19.8.6.1. Introduction 19.8.6.2. Market Analysis and Forecast by Market Taxonomy 19.8.6.2.1. By Product 19.8.6.2.2. By Indication 19.8.6.2.3. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players (%) 20.3. Market Presence Analysis 20.3.1. Regional Footprint of Players 20.3.2. Product Footprint of Players 20.3.3. Channel Footprint of Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Key Development Analysis 21.3. Branding and Promotional Strategies, By Key Players 21.4. Competition Deep Dive 21.4.1. Exact Sciences (Genome Health Inc.) 21.4.1.1. Overview 21.4.1.2. Product Portfolio 21.4.1.3. Key Financials 21.4.1.4. Sales Footprint 21.4.1.5. SWOT Analysis 21.4.1.6. Strategy Overview 21.4.1.6.1. Marketing Strategies 21.4.1.6.2. Channel Strategies 21.4.1.6.3. Product Strategies 21.4.2. NanoString Technologies, Inc. 21.4.2.1. Overview 21.4.2.2. Product Portfolio 21.4.2.3. Key Financials 21.4.2.4. Sales Footprint 21.4.2.5. SWOT Analysis 21.4.2.6. Strategy Overview 21.4.2.6.1. Marketing Strategies 21.4.2.6.2. Channel Strategies 21.4.2.6.3. Product Strategies 21.4.3. Foundation Medicine, Inc 21.4.3.1. Overview 21.4.3.2. Product Portfolio 21.4.3.3. Key Financials 21.4.3.4. Sales Footprint 21.4.3.5. SWOT Analysis 21.4.3.6. Strategy Overview 21.4.3.6.1. Marketing Strategies 21.4.3.6.2. Channel Strategies 21.4.3.6.3. Product Strategies 21.4.4. ThermoFisher Scientific 21.4.4.1. Overview 21.4.4.2. Product Portfolio 21.4.4.3. Key Financials 21.4.4.4. Sales Footprint 21.4.4.5. SWOT Analysis 21.4.4.6. Strategy Overview 21.4.4.6.1. Marketing Strategies 21.4.4.6.2. Channel Strategies 21.4.4.6.3. Product Strategies 21.4.5. Illumina, Inc 21.4.5.1. Overview 21.4.5.2. Product Portfolio 21.4.5.3. Key Financials 21.4.5.4. Sales Footprint 21.4.5.5. SWOT Analysis 21.4.5.6. Strategy Overview 21.4.5.6.1. Marketing Strategies 21.4.5.6.2. Channel Strategies 21.4.5.6.3. Product Strategies 21.4.6. Hologic Inc (Biotheranostic) 21.4.6.1. Overview 21.4.6.2. Product Portfolio 21.4.6.3. Key Financials 21.4.6.4. Sales Footprint 21.4.6.5. SWOT Analysis 21.4.6.6. Strategy Overview 21.4.6.6.1. Marketing Strategies 21.4.6.6.2. Channel Strategies 21.4.6.6.3. Product Strategies 21.4.7. Biocartis 21.4.7.1. Overview 21.4.7.2. Product Portfolio 21.4.7.3. Key Financials 21.4.7.4. Sales Footprint 21.4.7.5. SWOT Analysis 21.4.7.6. Strategy Overview 21.4.7.6.1. Marketing Strategies 21.4.7.6.2. Channel Strategies 21.4.7.6.3. Product Strategies 21.4.8. Roche Diagnostics 21.4.8.1. Overview 21.4.8.2. Product Portfolio 21.4.8.3. Key Financials 21.4.8.4. Sales Footprint 21.4.8.5. SWOT Analysis 21.4.8.6. Strategy Overview 21.4.8.6.1. Marketing Strategies 21.4.8.6.2. Channel Strategies 21.4.8.6.3. Product Strategies 21.4.9. Epic Sciences 21.4.9.1. Overview 21.4.9.2. Product Portfolio 21.4.9.3. Key Financials 21.4.9.4. Sales Footprint 21.4.9.5. SWOT Analysis 21.4.9.6. Strategy Overview 21.4.9.6.1. Marketing Strategies 21.4.9.6.2. Channel Strategies 21.4.9.6.3. Product Strategies 21.4.10. Qiagen 21.4.10.1. Overview 21.4.10.2. Product Portfolio 21.4.10.3. Key Financials 21.4.10.4. Sales Footprint 21.4.10.5. SWOT Analysis 21.4.10.6. Strategy Overview 21.4.10.6.1. Marketing Strategies 21.4.10.6.2. Channel Strategies 21.4.10.6.3. Product Strategies 21.4.11. Abbott 21.4.11.1. Overview 21.4.11.2. Product Portfolio 21.4.11.3. Key Financials 21.4.11.4. Sales Footprint 21.4.11.5. SWOT Analysis 21.4.11.6. Strategy Overview 21.4.11.6.1. Marketing Strategies 21.4.11.6.2. Channel Strategies 21.4.11.6.3. Product Strategies 21.4.12. Myriad Genetics, Inc 21.4.12.1. Overview 21.4.12.2. Product Portfolio 21.4.12.3. Key Financials 21.4.12.4. Sales Footprint 21.4.12.5. SWOT Analysis 21.4.12.6. Strategy Overview 21.4.12.6.1. Marketing Strategies 21.4.12.6.2. Channel Strategies 21.4.12.6.3. Product Strategies 21.4.13. Guardant Health 21.4.13.1. Overview 21.4.13.2. Product Portfolio 21.4.13.3. Key Financials 21.4.13.4. Sales Footprint 21.4.13.5. SWOT Analysis 21.4.13.6. Strategy Overview 21.4.13.6.1. Marketing Strategies 21.4.13.6.2. Channel Strategies 21.4.13.6.3. Product Strategies 22. Assumptions and Acronyms Used 23. Research Methodology
SummaryBreast Recurrence Score Test Market: Report Scope Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption Analysis 4.2. Product USPs/Features 4.3. Regulatory Landscape, By Country 4.4. Recent Product Approval/Launches 4.5. Disease Epidemiology 4.6. PESTLE Analysis 4.7. Value Chain Analysis 4.8. Unmet Needs 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure Outlook 5.1.2. Global Life Science Market Outlook 5.1.3. Global Breast Cancer Diagnostics Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising Prevalence of Breast Cancer 5.2.2. Increase in Research and Development 5.2.3. Strategic Collaborations among players 5.2.4. Cost of Product 5.2.5. Adoption Rate 5.2.6. Frequency of Product Approval 5.2.7. Government Initiative 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand Volume (Units) Analysis 2017–2022 and Forecast, 2023–2033 6.1. Historical Market Volume (Units) Analysis, 2017–2022 6.2. Current and Future Market Volume (Units) Projections, 2023–2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market – Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Global Average Pricing Analysis Benchmark 7.3. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017–2022 and Forecast, 2023–2033 8.1. Historical Market Value (US$ Mn) Analysis, 2017–2022 8.2. Current and Future Market Size (US$ Mn) Projections, 2023–2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic 9. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2017–2022 9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2023–2033 9.3.1. Test Kits 9.3.2. Reagents & Consumables 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Indication 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2017–2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023–2033 10.3.1. Stage 1 Breast Cancer 10.3.2. Stage 2 Breast Cancer 10.3.3. Estrogen-receptor Positive Cancer 10.3.4. Lymph-node Negative Cancer 10.4. Market Attractiveness Analysis By Indication 11. Global Market Analysis 2017–2022 and Forecast 2023–2033, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033 11.3.1. Hospitals 11.3.2. Specialty Cancer Centers 11.3.3. Diagnostic Centers 11.3.4. Cancer Research Institutions 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2017–2022 and Forecast 2023–2033, by Region 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2017–2022 12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Region, 2023–2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East and Africa 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2017–2022 and Forecast 2023–2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Indication 13.3.4. By End User 13.4. Market Attractiveness Analysis By Region 13.4.1. By Country 13.4.2. By Product 13.4.3. By Indication 13.4.4. By End User 13.5. Market trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country Level Analysis & Forecast 13.8.1. U.S. Market Analysis 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Product 13.8.1.2.2. By Indication 13.8.1.2.3. By End User 13.8.2. Canada Market Analysis 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Product 13.8.2.2.2. By Indication 13.8.2.2.3. By End User 14. Latin America Market Analysis 2017–2022 and Forecast 2023–2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By Indication 14.3.4. By End User 14.4. Market Attractiveness Analysis By Region 14.4.1. By Country 14.4.2. By Product 14.4.3. By Indication 14.4.4. By End User 14.5. Market trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. Brazil Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Product 14.8.1.2.2. By Indication 14.8.1.2.3. By End User 14.8.2. Mexico Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Product 14.8.2.2.2. By Indication 14.8.2.2.3. By End User 14.8.3. Argentina Market Analysis 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Product 14.8.3.2.2. By Indication 14.8.3.2.3. Type By End User 15. Europe Market Analysis 2017–2022 and Forecast 2023–2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2017–2022 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. France 15.3.1.3. Spain 15.3.1.4. Russia 15.3.1.5. Italy 15.3.1.6. BENELUX 15.3.1.7. U.K. 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By Indication 15.3.4. By End User 15.4. Market Attractiveness Analysis By Region 15.4.1. By Country 15.4.2. By Product 15.4.3. By Indication 15.4.4. By End User 15.5. Market trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. Germany Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By Indication 15.8.1.2.3. By End User 15.8.2. France Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By Indication 15.8.2.2.3. By End User 15.8.3. Spain Market Analysis 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Product 15.8.3.2.2. By Indication 15.8.3.2.3. Type By End User 15.8.4. Russia Market Analysis 15.8.4.1. Introduction 15.8.4.2. Market Analysis and Forecast by Market Taxonomy 15.8.4.2.1. By Product 15.8.4.2.2. By Indication 15.8.4.2.3. Type By End User 15.8.5. Italy Market Analysis 15.8.5.1. Introduction 15.8.5.2. Market Analysis and Forecast by Market Taxonomy 15.8.5.2.1. By Product 15.8.5.2.2. By Indication 15.8.5.2.3. By End User 15.8.6. BENELUX Market Analysis 15.8.6.1. Introduction 15.8.6.2. Market Analysis and Forecast by Market Taxonomy 15.8.6.2.1. By Product 15.8.6.2.2. By Indication 15.8.6.2.3. By End User 15.8.7. U.K. Market Analysis 15.8.7.1. Introduction 15.8.7.2. Market Analysis and Forecast by Market Taxonomy 15.8.7.2.1. By Product 15.8.7.2.2. By Indication 15.8.7.2.3. By End User 16. East Asia Market Analysis 2017–2022 and Forecast 2023–2033 16.1. Introduction / Key Findings 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Product 16.3.3. By Indication 16.3.4. By End User 16.4. Market Attractiveness Analysis By Region 16.4.1. By Country 16.4.2. By Product 16.4.3. By Indication 16.4.4. By End User 16.5. Market trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. China Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By Indication 16.8.1.2.3. By End User 16.8.2. Japan Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By Indication 16.8.2.2.3. By End User 16.8.3. South Korea Market Analysis 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By Indication 16.8.3.2.3. By End User 17. South Asia Market Analysis 2017–2022 and Forecast 2023–2033 17.1. Introduction / Key Findings 17.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2017–2022 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Indonesia 17.3.1.3. Thailand 17.3.1.4. Philippines 17.3.1.5. Malaysia 17.3.1.6. Vietnam 17.3.1.7. Rest of South Asia 17.3.2. By Product 17.3.3. By Indication 17.3.4. By End User 17.4. Market Attractiveness Analysis By Region 17.4.1. By Country 17.4.2. By Product 17.4.3. By Indication 17.4.4. By End User 17.5. Market trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. India Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Indication 17.8.1.2.3. By End User 17.8.2. Indonesia Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Indication 17.8.2.2.3. By End User 17.8.3. Thailand Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By Indication 17.8.3.2.3. By End User 17.8.4. Philippines Market Analysis 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Product 17.8.4.2.2. By Indication 17.8.4.2.3. By End User 17.8.5. Malaysia Market Analysis 17.8.5.1. Introduction 17.8.5.2. Market Analysis and Forecast by Market Taxonomy 17.8.5.2.1. By Product 17.8.5.2.2. By Indication 17.8.5.2.3. By End User 17.8.6. Vietnam Market Analysis 17.8.6.1. Introduction 17.8.6.2. Market Analysis and Forecast by Market Taxonomy 17.8.6.2.1. By Product 17.8.6.2.2. By Indication 17.8.6.2.3. By End User 18. Oceania Market Analysis 2017–2022 and Forecast 2023–2033 18.1. Introduction / Key Findings 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022 18.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Indication 18.3.4. By End User 18.4. Market Attractiveness Analysis By Region 18.4.1. By Country 18.4.2. By Product 18.4.3. By Indication 18.4.4. By End User 18.5. Market trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. Australia Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Indication 18.8.1.2.3. By End User 18.8.2. New Zealand Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Indication 18.8.2.2.3. By End User 19. Middle East and Africa Market Analysis 2017–2022 and Forecast 2023–2033 19.1. Introduction / Key Findings 19.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2017–2022 19.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. Egypt 19.3.1.4. Israel 19.3.1.5. South Africa 19.3.1.6. Northern Africa 19.3.1.7. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Indication 19.3.4. By End User 19.4. Market Attractiveness Analysis By Region 19.4.1. By Country 19.4.2. By Product 19.4.3. By Indication 19.4.4. By End User 19.5. Market trends 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country Level Analysis & Forecast 19.8.1. GCC Countries Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Indication 19.8.1.2.3. By End User 19.8.2. Türkiye Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Indication 19.8.2.2.3. By End User 19.8.3. Egypt Market Analysis 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By Indication 19.8.3.2.3. By End User 19.8.4. Israel Market Analysis 19.8.4.1. Introduction 19.8.4.2. Market Analysis and Forecast by Market Taxonomy 19.8.4.2.1. By Product 19.8.4.2.2. By Indication 19.8.4.2.3. By End User 19.8.5. South Africa Market Analysis 19.8.5.1. Introduction 19.8.5.2. Market Analysis and Forecast by Market Taxonomy 19.8.5.2.1. By Product 19.8.5.2.2. By Indication 19.8.5.2.3. By End User 19.8.6. Northern Africa Market Analysis 19.8.6.1. Introduction 19.8.6.2. Market Analysis and Forecast by Market Taxonomy 19.8.6.2.1. By Product 19.8.6.2.2. By Indication 19.8.6.2.3. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players (%) 20.3. Market Presence Analysis 20.3.1. Regional Footprint of Players 20.3.2. Product Footprint of Players 20.3.3. Channel Footprint of Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Key Development Analysis 21.3. Branding and Promotional Strategies, By Key Players 21.4. Competition Deep Dive 21.4.1. Exact Sciences (Genome Health Inc.) 21.4.1.1. Overview 21.4.1.2. Product Portfolio 21.4.1.3. Key Financials 21.4.1.4. Sales Footprint 21.4.1.5. SWOT Analysis 21.4.1.6. Strategy Overview 21.4.1.6.1. Marketing Strategies 21.4.1.6.2. Channel Strategies 21.4.1.6.3. Product Strategies 21.4.2. NanoString Technologies, Inc. 21.4.2.1. Overview 21.4.2.2. Product Portfolio 21.4.2.3. Key Financials 21.4.2.4. Sales Footprint 21.4.2.5. SWOT Analysis 21.4.2.6. Strategy Overview 21.4.2.6.1. Marketing Strategies 21.4.2.6.2. Channel Strategies 21.4.2.6.3. Product Strategies 21.4.3. Foundation Medicine, Inc 21.4.3.1. Overview 21.4.3.2. Product Portfolio 21.4.3.3. Key Financials 21.4.3.4. Sales Footprint 21.4.3.5. SWOT Analysis 21.4.3.6. Strategy Overview 21.4.3.6.1. Marketing Strategies 21.4.3.6.2. Channel Strategies 21.4.3.6.3. Product Strategies 21.4.4. ThermoFisher Scientific 21.4.4.1. Overview 21.4.4.2. Product Portfolio 21.4.4.3. Key Financials 21.4.4.4. Sales Footprint 21.4.4.5. SWOT Analysis 21.4.4.6. Strategy Overview 21.4.4.6.1. Marketing Strategies 21.4.4.6.2. Channel Strategies 21.4.4.6.3. Product Strategies 21.4.5. Illumina, Inc 21.4.5.1. Overview 21.4.5.2. Product Portfolio 21.4.5.3. Key Financials 21.4.5.4. Sales Footprint 21.4.5.5. SWOT Analysis 21.4.5.6. Strategy Overview 21.4.5.6.1. Marketing Strategies 21.4.5.6.2. Channel Strategies 21.4.5.6.3. Product Strategies 21.4.6. Hologic Inc (Biotheranostic) 21.4.6.1. Overview 21.4.6.2. Product Portfolio 21.4.6.3. Key Financials 21.4.6.4. Sales Footprint 21.4.6.5. SWOT Analysis 21.4.6.6. Strategy Overview 21.4.6.6.1. Marketing Strategies 21.4.6.6.2. Channel Strategies 21.4.6.6.3. Product Strategies 21.4.7. Biocartis 21.4.7.1. Overview 21.4.7.2. Product Portfolio 21.4.7.3. Key Financials 21.4.7.4. Sales Footprint 21.4.7.5. SWOT Analysis 21.4.7.6. Strategy Overview 21.4.7.6.1. Marketing Strategies 21.4.7.6.2. Channel Strategies 21.4.7.6.3. Product Strategies 21.4.8. Roche Diagnostics 21.4.8.1. Overview 21.4.8.2. Product Portfolio 21.4.8.3. Key Financials 21.4.8.4. Sales Footprint 21.4.8.5. SWOT Analysis 21.4.8.6. Strategy Overview 21.4.8.6.1. Marketing Strategies 21.4.8.6.2. Channel Strategies 21.4.8.6.3. Product Strategies 21.4.9. Epic Sciences 21.4.9.1. Overview 21.4.9.2. Product Portfolio 21.4.9.3. Key Financials 21.4.9.4. Sales Footprint 21.4.9.5. SWOT Analysis 21.4.9.6. Strategy Overview 21.4.9.6.1. Marketing Strategies 21.4.9.6.2. Channel Strategies 21.4.9.6.3. Product Strategies 21.4.10. Qiagen 21.4.10.1. Overview 21.4.10.2. Product Portfolio 21.4.10.3. Key Financials 21.4.10.4. Sales Footprint 21.4.10.5. SWOT Analysis 21.4.10.6. Strategy Overview 21.4.10.6.1. Marketing Strategies 21.4.10.6.2. Channel Strategies 21.4.10.6.3. Product Strategies 21.4.11. Abbott 21.4.11.1. Overview 21.4.11.2. Product Portfolio 21.4.11.3. Key Financials 21.4.11.4. Sales Footprint 21.4.11.5. SWOT Analysis 21.4.11.6. Strategy Overview 21.4.11.6.1. Marketing Strategies 21.4.11.6.2. Channel Strategies 21.4.11.6.3. Product Strategies 21.4.12. Myriad Genetics, Inc 21.4.12.1. Overview 21.4.12.2. Product Portfolio 21.4.12.3. Key Financials 21.4.12.4. Sales Footprint 21.4.12.5. SWOT Analysis 21.4.12.6. Strategy Overview 21.4.12.6.1. Marketing Strategies 21.4.12.6.2. Channel Strategies 21.4.12.6.3. Product Strategies 21.4.13. Guardant Health 21.4.13.1. Overview 21.4.13.2. Product Portfolio 21.4.13.3. Key Financials 21.4.13.4. Sales Footprint 21.4.13.5. SWOT Analysis 21.4.13.6. Strategy Overview 21.4.13.6.1. Marketing Strategies 21.4.13.6.2. Channel Strategies 21.4.13.6.3. Product Strategies 22. Assumptions and Acronyms Used 23. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポートPersistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ(Persistence Market Research/PMR)は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |